Hypertension in obese children is associated with vitamin D deficiency and serotonin dysregulation
Jazyk angličtina Země Velká Británie, Anglie Médium electronic
Typ dokumentu časopisecké články
PubMed
35581625
PubMed Central
PMC9112480
DOI
10.1186/s12887-022-03337-8
PII: 10.1186/s12887-022-03337-8
Knihovny.cz E-zdroje
- Klíčová slova
- Children, Hypertension, Obesity, Serotonin, Vitamin D,
- MeSH
- ambulantní monitorování krevního tlaku MeSH
- dítě MeSH
- hypertenze * epidemiologie MeSH
- index tělesné hmotnosti MeSH
- inzulin MeSH
- inzulinová rezistence * MeSH
- lidé MeSH
- nedostatek vitaminu D * MeSH
- obezita dětí a dospívajících * komplikace epidemiologie MeSH
- prospektivní studie MeSH
- průřezové studie MeSH
- serotonin MeSH
- vitamin D MeSH
- vitaminy MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- inzulin MeSH
- serotonin MeSH
- vitamin D MeSH
- vitaminy MeSH
BACKGROUND: Obesity and hypertension represent serious health issues affecting the pediatric population with increasing prevalence. Hypovitaminosis D has been suggested to be associated with arterial hypertension. Serotonin by modulating nitric oxide synthase affect blood pressure regulation. The biological mechanism by which vitamin D specifically regulates serotonin synthesis was recently described. The aim of this paper is to determine the associations between vitamin D, serotonin, and blood pressure in obese children. METHODS: One hundred and seventy-one children were enrolled in the prospective cross-sectional study. Two groups of children divided according to body mass index status to obese (BMI ≥95th percentile; n = 120) and non-obese (n = 51) were set. All children underwent office and ambulatory blood pressure monitoring and biochemical analysis of vitamin D and serotonin. Data on fasting glucose, insulin, HOMA, uric acid, and complete lipid profile were obtained in obese children. RESULTS: Hypertension was found only in the group of obese children. Compared to the control group, obese children had lower vitamin D and serotonin, especially in winter. The vitamin D seasonality and BMI-SDS were shown as the most significant predictors of systolic blood pressure changes, while diastolic blood pressure was predicted mostly by insulin and serotonin. The presence of hypertension and high-normal blood pressure in obese children was most significantly affected by vitamin D deficiency and increased BMI-SDS. CONCLUSIONS: Dysregulation of vitamin D and serotonin can pose a risk of the onset and development of hypertension in obese children; therefore, their optimization together with reducing body weight may improve the long-term cardiovascular health of these children.
Zobrazit více v PubMed
Babinska K, Kovacs L, Janko V, Dallos T, Feber J. Association between obesity and the severity of ambulatory hypertension in children and adolescents. J Am Soc Hypertens. 2012;6(5):356–363. doi: 10.1016/j.jash.2012.08.002. PubMed DOI
Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, et al. Clinical practice guideline for screening and Management of High Blood Pressure in children and adolescents. Pediatrics. 2017;140(3):e20171904. doi: 10.1542/peds.2017-1904. PubMed DOI
Seeman T, Dostálek L, Gilík J. Control of hypertension in treated children and its association with target organ damage. Am J Hypertens. 2012;25(3):389–395. doi: 10.1038/ajh.2011.218. PubMed DOI
Flechtner-Mors M, Neuhauser H, Reinehr T, Roost HP, Wiegand S, Siegfried W, et al. Blood pressure in 57,915 pediatric patients who are overweight or obese based on five reference systems. Am J Cardiol. 2015;115(11):1587–1594. doi: 10.1016/j.amjcard.2015.02.063. PubMed DOI
Flynn J. The changing face of pediatric hypertension in the era of the childhood obesity epidemic. Pediatr Nephrol. 2013;28(7):1059–1066. doi: 10.1007/s00467-012-2344-0. PubMed DOI
Shariq OA, McKenzie TJ. Obesity-related hypertension: a review of pathophysiology, management, and the role of metabolic surgery. Gland Surg. 2020;9(1):80–93. doi: 10.21037/gs.2019.12.03. PubMed DOI PMC
Hall JE, Mouton A, da Silva AA, Omoto ACM, Wang Z, Li X, et al. Obesity, kidney dysfunction and inflammation: interactions in hypertension. Cardiovasc Res. 2020;117(8):1859–1876. doi: 10.1093/cvr/cvaa336. PubMed DOI PMC
Orlando A, Cazzaniga E, Giussani M, Palestini P, Genovesi S. Hypertension in children: role of obesity, simple carbohydrates, and uric acid. Front. Public Health. 2018;6:129. PubMed PMC
Burrows R, Correa-Burrows P, Rogan J, Cheng E, Blanco E, Gahagan S. Long-term vs. recent-onset obesity: their contribution to cardiometabolic risk in adolescence. Pediatr Res. 2019;86(6):776–782. doi: 10.1038/s41390-019-0543-0. PubMed DOI PMC
Zakharova I, Klimov L, Kuryaninova V, Nikitina I, Malyavskaya S, Dolbnya S, et al. Vitamin D insufficiency in overweight and obese children and adolescents. Front Endocrinol (Lausanne) 2019;10:103. doi: 10.3389/fendo.2019.00103. PubMed DOI PMC
Asghari G, Yuzbashian E, Wagner CL, Park Y, Mirmiran P, Hosseinpanah F. Daily vitamin D(3) in overweight and obese children and adolescents: a randomized controlled trial. Eur J Nutr. 2021;60(5):2831–2840. doi: 10.1007/s00394-020-02406-x. PubMed DOI
Szymczak-Pajor I, Śliwińska A. Analysis of association between vitamin D deficiency and insulin resistance. Nutrients. 2019;11(4):794. doi: 10.3390/nu11040794. PubMed DOI PMC
Alonso MA, Mantecón L, Santos F. Vitamin D deficiency in children: a challenging diagnosis! Pediatr Res. 2019;85(5):596–601. doi: 10.1038/s41390-019-0289-8. PubMed DOI
Kao KT, Abidi N, Ranasinha S, Brown J, Rodda C, McCallum Z, et al. Low vitamin D is associated with hypertension in paediatric obesity. J Paediatr Child Health. 2015;51(12):1207–1213. doi: 10.1111/jpc.12935. PubMed DOI
Moore CE, Liu Y. Elevated systolic blood pressure of children in the United States is associated with low serum 25-hydroxyvitamin D concentrations related to body mass index: National Health and examination survey 2007-2010. Nutr Res. 2017;38:64–70. doi: 10.1016/j.nutres.2017.01.008. PubMed DOI
Kheiri B, Abdalla A, Osman M, Ahmed S, Hassan M, Bachuwa G. Vitamin D deficiency and risk of cardiovascular diseases: a narrative review. Clin Hypertens. 2018;24(1):9. doi: 10.1186/s40885-018-0094-4. PubMed DOI PMC
Jia G, Aroor AR, Hill MA, Sowers JR. Role of renin-angiotensin-aldosterone system activation in promoting cardiovascular fibrosis and stiffness. Hypertension. 2018;72(3):537–548. doi: 10.1161/HYPERTENSIONAHA.118.11065. PubMed DOI PMC
Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol. 2004;89-90(1–5):387–392. doi: 10.1016/j.jsbmb.2004.03.004. PubMed DOI
Zittermann A, Ernst JB, Prokop S, Fuchs U, Dreier J, Kuhn J, et al. Effects of vitamin D supplementation on renin and aldosterone concentrations in patients with advanced heart failure: the EVITA trial. Int J Endocrinol. 2018;2018:5015417. doi: 10.1155/2018/5015417. PubMed DOI PMC
Kim D-H, Meza CA, Clarke H, Kim J-S, Hickner RC. Vitamin D and endothelial function. Nutrients. 2020;12(2):575. doi: 10.3390/nu12020575. PubMed DOI PMC
Patrick RP, Ames BN. Vitamin D hormone regulates serotonin synthesis. Part 1: relevance for autism. FASEB J. 2014;28(6):2398–2413. doi: 10.1096/fj.13-246546. PubMed DOI
Watts SW, Morrison SF, Davis RP, Barman SM. Serotonin and blood pressure regulation. Pharmacol Rev. 2012;64(2):359–388. doi: 10.1124/pr.111.004697. PubMed DOI PMC
Vanhoutte PM. Serotonin and the vascular wall. Int J Cardiol. 1987;14(2):189–203. doi: 10.1016/0167-5273(87)90008-8. PubMed DOI
Frishman WH, Grewall P. Serotonin and the heart. Ann Med. 2000;32(3):195–209. doi: 10.3109/07853890008998827. PubMed DOI
Ševčíková L, Hamade J, Nováková J, Tatara M. Rast a vývojové trendy slovenských detí a mládeže za posledných 10 rokov. ÚVZSR. 2004:192–206.
Ševčíková L, Štefániková Z, Jurkovičová J, Nováková J, Hamade J, Ághová Ľ. Telesný vývoj detí a mládeže v SR. ÚVZSR. 2004:184.
Lurbe E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, Erdine S, Hirth A, et al. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens. 2016;34(10):1887–1920. doi: 10.1097/HJH.0000000000001039. PubMed DOI
Meng L, Zhao D, Pan Y, Ding W, Wei Q, Li H, et al. Validation of Omron HBP-1300 professional blood pressure monitor based on auscultation in children and adults. BMC Cardiovasc Disord. 2016;16:9. doi: 10.1186/s12872-015-0177-z. PubMed DOI PMC
Neuhauser HK, Thamm M, Ellert U, Hense HW, Rosario AS. Blood pressure percentiles by age and height from nonoverweight children and adolescents in Germany. Pediatrics. 2011;127(4):e978–e988. doi: 10.1542/peds.2010-1290. PubMed DOI
Wühl E, Witte K, Soergel M, Mehls O, Schaefer F. Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens. 2002;20(10):1995–2007. doi: 10.1097/00004872-200210000-00019. PubMed DOI
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930. doi: 10.1210/jc.2011-0385. PubMed DOI
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502. doi: 10.1093/clinchem/18.6.499. PubMed DOI
Singh Y, Garg MK, Tandon N, Marwaha RK. A study of insulin resistance by HOMA-IR and its cut-off value to identify metabolic syndrome in urban Indian adolescents. J Clin Res Pediatr Endocrinol. 2013;5(4):245–251. doi: 10.4274/Jcrpe.1127. PubMed DOI PMC
Sorof JM, Poffenbarger T, Franco K, Bernard L, Portman RJ. Isolated systolic hypertension, obesity, and hyperkinetic hemodynamic states in children. J Pediatr. 2002;140(6):660–666. doi: 10.1067/mpd.2002.125228. PubMed DOI
Maldonado J, Pereira T, Fernandes R, Santos R, Carvalho M. An approach of hypertension prevalence in a sample of 5381 Portuguese children and adolescents. The AVELEIRA registry. "hypertension in children". Blood Press. 2011;20(3):153–157. doi: 10.3109/08037051.2010.542649. PubMed DOI
Sypniewska G. Laboratory assessment of cardiometabolic risk in overweight and obese children. Clin Biochem. 2015;48(6):370–376. doi: 10.1016/j.clinbiochem.2014.12.024. PubMed DOI
Lurbe E, Torro MI, Alvarez-Pitti J, Redon P, Redon J. Central blood pressure and pulse wave amplification across the spectrum of peripheral blood pressure in overweight and obese youth. J Hypertens. 2016;34(7):1389–1395. doi: 10.1097/HJH.0000000000000933. PubMed DOI
Mollerup PM, Lausten-Thomsen U, Fonvig CE, Baker JL, Holm JC. Reductions in blood pressure during a community-based overweight and obesity treatment in children and adolescents with prehypertension and hypertension. J Hum Hypertens. 2017;31(10):640–646. doi: 10.1038/jhh.2017.36. PubMed DOI
Šuláková T, Šuláková A, Strnadel J, Pavlíček J, Obermannová B, Feber J. Can auscultatory blood pressure normative values be used for evaluation of oscillometric blood pressure in children? J Clin Hypertens (Greenwich) 2017;19(4):381–387. doi: 10.1111/jch.12943. PubMed DOI PMC
Brambilla P, Antolini L, Street ME, Giussani M, Galbiati S, Valsecchi MG, et al. Adiponectin and hypertension in normal-weight and obese children. Am J Hypertens. 2013;26(2):257–264. doi: 10.1093/ajh/hps033. PubMed DOI
Manios Y, Karatzi K, Protogerou AD, Moschonis G, Tsirimiagou C, Androutsos O, et al. Prevalence of childhood hypertension and hypertension phenotypes by weight status and waist circumference: the healthy growth study. Eur J Nutr. 2018;57(3):1147–1155. doi: 10.1007/s00394-017-1398-y. PubMed DOI
Cheung EL, Bell CS, Samuel JP, Poffenbarger T, Redwine KM, Samuels JA. Race and obesity in adolescent hypertension. Pediatrics. 2017;139(5):e20161433. doi: 10.1542/peds.2016-1433. PubMed DOI PMC
Guzzetti C, Ibba A, Casula L, Pilia S, Casano S, Loche S. Cardiovascular risk factors in children and adolescents with obesity: sex-related differences and effect of puberty. Front Endocrinol (Lausanne). 2019;10:591. doi: 10.3389/fendo.2019.00591. PubMed DOI PMC
Reue K. Sex differences in obesity: X chromosome dosage as a risk factor for increased food intake, adiposity and co-morbidities. Physiol Behav. 2017;176:174–182. doi: 10.1016/j.physbeh.2017.02.040. PubMed DOI PMC
Palmer BF, Clegg DJ. The sexual dimorphism of obesity. Mol Cell Endocrinol. 2015;402:113–119. doi: 10.1016/j.mce.2014.11.029. PubMed DOI PMC
Mauvais-Jarvis F. Gender differences in glucose homeostasis and diabetes. Physiol Behav. 2018;187:20–23. doi: 10.1016/j.physbeh.2017.08.016. PubMed DOI PMC
Moran A, Jacobs DR, Jr, Steinberger J, Steffen LM, Pankow JS, Hong CP, et al. Changes in insulin resistance and cardiovascular risk during adolescence: establishment of differential risk in males and females. Circulation. 2008;117(18):2361–2368. doi: 10.1161/CIRCULATIONAHA.107.704569. PubMed DOI
Moran A, Jacobs DR, Jr, Steinberger J, Hong CP, Prineas R, Luepker R, et al. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes. 1999;48(10):2039–2044. doi: 10.2337/diabetes.48.10.2039. PubMed DOI
Reinehr T, Wolters B, Knop C, Lass N, Holl RW. Strong effect of pubertal status on metabolic health in obese children: a longitudinal study. J Clin Endocrinol Metab. 2015;100(1):301–308. doi: 10.1210/jc.2014-2674. PubMed DOI
Kelsey MM, Zeitler PS. Insulin resistance of puberty. Curr Diab Rep. 2016;16(7):64. doi: 10.1007/s11892-016-0751-5. PubMed DOI
Goran MI, Gower BA. Longitudinal study on pubertal insulin resistance. Diabetes. 2001;50(11):2444–2450. doi: 10.2337/diabetes.50.11.2444. PubMed DOI
Kelly LA, Lane CJ, Weigensberg MJ, Toledo-Corral CM, Goran MI. Pubertal changes of insulin sensitivity, acute insulin response, and β-cell function in overweight Latino youth. J Pediatr. 2011;158(3):442–446. doi: 10.1016/j.jpeds.2010.08.046. PubMed DOI PMC
Siervogel RM, Demerath EW, Schubert C, Remsberg KE, Chumlea WC, Sun S, et al. Puberty and body composition. Horm Res. 2003;60(Suppl 1):36–45. PubMed
Natali A, Ferrannini E. Hypertension, insulin resistance, and the metabolic syndrome. Endocrinol Metab Clin N Am. 2004;33(2):417–429. doi: 10.1016/j.ecl.2004.03.007. PubMed DOI
Marcovecchio ML, Patricelli L, Zito M, Capanna R, Ciampani M, Chiarelli F, et al. Ambulatory blood pressure monitoring in obese children: role of insulin resistance. J Hypertens. 2006;24(12):2431–2436. doi: 10.1097/HJH.0b013e328010918b. PubMed DOI
Kotchen TA. Obesity-related hypertension: epidemiology, pathophysiology, and clinical management. Am J Hypertens. 2010;23(11):1170–1178. doi: 10.1038/ajh.2010.172. PubMed DOI
Makni E, Moalla W, Benezzeddine-Boussaidi L, Lac G, Tabka Z, Elloumi M. Correlation of resistin with inflammatory and cardiometabolic markers in obese adolescents with and without metabolic syndrome. Obes Facts. 2013;6(4):393–404. doi: 10.1159/000354574. PubMed DOI PMC
Hodge S, Bunting BP, Carr E, Strain JJ, Stewart-Knox BJ. Obesity, whole blood serotonin and sex differences in healthy volunteers. Obes Facts. 2012;5(3):399–407. doi: 10.1159/000339981. PubMed DOI
Binetti J, Bertran L, Riesco D, Aguilar C, Martínez S, Sabench F, et al. Deregulated serotonin pathway in women with morbid obesity and NAFLD. Life (Basel) 2020;10(10):245. PubMed PMC
Ritze Y, Schollenberger A, Hamze Sinno M, Bühler N, Böhle M, Bárdos G, et al. Gastric ghrelin, GOAT, leptin, and leptinR expression as well as peripheral serotonin are dysregulated in humans with obesity. Neurogastroenterol Motil. 2016;28(6):806–815. doi: 10.1111/nmo.12773. PubMed DOI
Kim HJ, Kim JH, Noh S, Hur HJ, Sung MJ, Hwang JT, et al. Metabolomic analysis of livers and serum from high-fat diet induced obese mice. J Proteome Res. 2011;10(2):722–731. doi: 10.1021/pr100892r. PubMed DOI
Bertrand RL, Senadheera S, Markus I, Liu L, Howitt L, Chen H, et al. A Western diet increases serotonin availability in rat small intestine. Endocrinology. 2011;152(1):36–47. doi: 10.1210/en.2010-0377. PubMed DOI
Pacifico L, Anania C, Osborn JF, Ferraro F, Bonci E, Olivero E, et al. Low 25(OH)D3 levels are associated with total adiposity, metabolic syndrome, and hypertension in Caucasian children and adolescents. Eur J Endocrinol. 2011;165(4):603–611. doi: 10.1530/EJE-11-0545. PubMed DOI
Rajakumar K, Moore CG, Khalid AT, Vallejo AN, Virji MA, Holick MF, et al. Effect of vitamin D3 supplementation on vascular and metabolic health of vitamin D-deficient overweight and obese children: a randomized clinical trial. Am J Clin Nutr. 2020;111(4):757–768. doi: 10.1093/ajcn/nqz340. PubMed DOI PMC